Showing 641-650 of 3302 results for "".
The Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.How Do You Manage the Aesthetic Patient?
https://practicaldermatology.com/topics/practice-management/how-do-you-manage-the-aesthetic-patient/18775/Managing the aesthetic patient is all about building relationships explains Joel L. Cohen, MD, founder of AboutSkin Dermatology in Englewood, CO. Dr. Cohen speaks with host Adam Friedman, MD, Associate Professor of Dermatology, Director, Residency Program, and Director, Translational Research at TheTaylor Made: One-of-a-kind Solutions for Device-based Services
https://practicaldermatology.com/topics/practice-management/taylor-made-one-of-a-kind-solutions-for-device-based-services/18789/An expert on the leading edge of device-based interventions, Mark B. Taylor, MD has learned when and how to adopt technologies and how to get the most from the systems in his practice. In this edition of Best Practices in Aesthetics, host Joel L. Cohen, MD asks Dr. Taylor to share his tips for optimSkin Cancer Prevention, Mohs Data, Allergan Closes on Zeltiq
https://practicaldermatology.com/topics/practice-management/dermwiretv-skin-cancer-prevention-mohs-data-allergan-closes-on-zeltiq/18479/It's Skin Cancer Awareness Month. Joel L. Cohen, MD and Shadi Kourosh, MD share tips on patient education and skin protection. Plus, new data set the stage for developing best practices for Mohs micrographic surgery. Wendy Lewis offers tips for digital marketing success. Plus, Allergan closes the deActinic Keratosis: Therapy Overview
https://practicaldermatology.com/topics/skin-cancer-photoprotection/actinic-keratosis-therapy-overview/19732/Joel Cohen, MD interviews George Martin, MD about the latest developments in actinic keratosis. Dr. Martin said he is eagerly awaiting regulatory review of tirbanibulin, which showed promising results in clinical trials. The two also discuss practical tips and nuances of using 5FU in practice. *Be sGold's Standards: Nashville's Laser Guru on Best Practices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/gold-s-standards-nashville-s-laser-guru-on-best-practices/18867/When a third of your practice is dedicated to energy-based devices, it's important to find the best solutions for your patient flow. In this edition of Best Practices, Joel L. Cohen, MD talks to Michael H. Gold, MD about his approach to adoption and promotion of energy-based devices. Dr. Gold discusMental Health Implications in Psoriasis
https://practicaldermatology.com/programs/practical-dermatology-il-17-journal-club/mental-health-implications-in-psoriasis/48771/Andrew Blauvelt, MD, MBA, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to talk about how IL-17 inhibition can reduce suicidal ideation and behavior in psoriasis patients, as covered in the Journal of the American Academy of Dermatology article “Mental health outcomes in paCan Treating Atopic Dermatitis Restore Growth in Children?
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/can-treating-atopic-dermatitis-restore-growth-in-children/50933/Practical Dermatology Editorial Board members Natasha Mesinkovska, MD, PhD, and Christopher Bunick, MD, FAAD, discuss the Journal of the American Academy of Dermatology article “Dupilumab, atopic dermatitis, and linear growth: Navigating beyond association to mechanism and intervention,” which featuReducing Atopic March Risk in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/reducing-atopic-march-risk-in-pediatric-atopic-dermatitis/54821/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, is joined by Editorial Board member Peter Lio, MD, to analyze the Journal of the American Academy of Dermatology article "Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus cIntegrity With Industry
https://practicaldermatology.com/programs/practical-dermatology/program-name/39883/Former Chair of the Board of Directors for the National Psoriasis Foundation Colby Evans, MD, provides an update on the SAFE Step Act, and Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, is joined by Jules Lipoff, Clinical Associate Professor (Adjunct) in the Lewis Katz School of M